

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Lorlatinib mushonga wekenza unovharira mapuroteni akati wandei anobatsira mamwe makenza emapapu kukura nekupararira. Mushonga uyu unopiwa nachiremba unobva kuboka rinonzi ALK inhibitors, iro rinoshanda nekukanganisa zviratidzo zvinoudza masero ekenza kuti awande.
Kana iwe kana mumwe munhu waunoda akanyorerwa lorlatinib, zvakajairika kuva nemibvunzo yekuti inoshanda sei uye zvekutarisira. Mushonga uyu unomiririra kufambira mberi kwakakosha mukurapa mhando dzakasiyana dzekenza yemumapapu, ichipa tariro uye mhedzisiro yakavandudzwa kune varwere vazhinji.
Lorlatinib mushonga wekurapa unovavarira kurapa non-small cell lung cancer (NSCLC) ine shanduko dzakasiyana dzemajini. Ndizvo zvinodaidzwa nachiremba kuti "mushonga wakarurama" nekuti unovavarira mapuroteni akati wandei anowanikwa mumasero ekenza akati wandei.
Mushonga uyu unouya semapiritsi anotorwa nemuromo. Kusiyana nechemotherapy yechinyakare iyo inokanganisa masero akawanda akasiyana mumuviri wako, lorlatinib inonyanya kuvavarira masero ekenza ane ALK kana ROS1 gene rearrangements. Iyi nzira yakatarwa kazhinji inoreva mativi mashoma emuviri kana ichienzaniswa nekurapa kwakakura kwekenza.
Chiremba wako acharayira kuyedzwa kwemajini etishu yako yegomarara kuti asimbise kana lorlatinib yakakodzera rudzi rwako rwekenza. Kuyedzwa uku kunobatsira kuona kuti unogamuchira kurapwa kunoshanda zvakanyanya kune mamiriro ako chaiwo.
Lorlatinib inorapa gomarara remumapapu risiri diki-seli iro rakapararira kune dzimwe nhengo dzemuviri. Kunyanya, inoshandiswa kana masero ako ekenza aine shanduko mumajini anonzi ALK (anaplastic lymphoma kinase) kana ROS1.
Mishonga iyi inowanzo perezverwa kana mamwe ma ALK inhibitors akarega kushanda zvakanaka. Inokosha zvikuru nekuti inogona kuyambuka chipingamupinyi cheropa-uropi, zvichiita kuti ishande kurwisa kenza yakapararira kuuropi. Varwere vazhinji vanowana izvi zvichivanyaradza zvikuru sezvo metastases yeuropi inogona kunetsa zvikuru.
Oncologist wako anogonawo kukurudzira lorlatinib sechinhu chekutanga chekurapa kana uine kenza yepfupa ye ALK-positive ichangobva kuongororwa. Sarudzo inoenderana nezvinhu zvakasiyana-siyana zvinosanganisira hutano hwako hwese, huwandu hwekenza yako, uye mamiriro ako ega.
Lorlatinib inoshanda nekudzivisa mapuroteni chaiwo anodiwa nemaseru ekenza kuti akure uye ararame. Funga nezve mapuroteni aya semaswitches anoudza maseru ekenza kuti awande uye apararire mumuviri wako.
Paunotora lorlatinib, inonamatira kumaswitches eprotein aya uye inova batidza. Chiito ichi chinomisa maseru ekenza kubva pakugamuchira zviratidzo zvaanoda kuti akure uye aparadzane. Somugumisiro, maseru ekenza anowanzo fa kana kumira kupararira kunzvimbo itsva dzemuviri wako.
Mishonga iyi inoonekwa seyakasimba uye inoshanda yekurapa yakatarwa. Inonyanya simba nekuti inogona kusvika kumasero ekenza muuropi, izvo zvimwe zvinodhaka zvekenza zvisingagoni kuita zvakanaka. Izvi zvinoita kuti ive inokosha zvikuru pakurapa kenza yepfupa yakapararira kuuropi.
Tora lorlatinib sezvinorayirwa nachiremba wako, kazhinji kamwe pazuva uine kana pasina chikafu. Unogona kuitora negirazi remvura chero nguva yezuva, asi edza kuitora panguva imwe chete zuva rega rega kuti ikubatsire kuyeuka.
Medza mahwendefa ese pasina kuapwanya, kuatsenga, kana kuapwanya. Kana uine dambudziko rekumedza mapiritsi, taura nechikwata chako chehutano nezve nzira dzinogona kubatsira. Vanogona kuva nezvirevo zvekurerutsa kutora mishonga yako.
Hamufaniri kutora lorlatinib pamwe chete nechikafu chipi nechipi chakakosha, asi kuchengetedza kudya kwakanaka panguva yekurapa kenza kwakakosha. Vamwe vanhu vanowana kuti kutora nemukanyiwa mudiki kunobatsira kudzivirira dumbu, kunyangwe izvi zvisingadiwi.
Dzivisa grapefruit uye muto wegrapefruit paunenge uchitora lorlatinib, sezvo izvi zvinogona kuwedzera huwandu hwemushonga muropa rako. Chiremba wako achakupa runyora rwakazara rwezvokudya nemishonga yekudzivisa.
Iwe unowanzoenderera mberi nekutora lorlatinib chero bedzi ichishanda nemazvo uye uchichigamuchira zvakanaka. Izvi zvinogona kuva mwedzi kana kunyange makore, zvichienderana nekuti kenza yako inopindura sei kurapwa.
Chiremba wako achatarisa kufambira mberi kwako kuburikidza nekuongorora nguva dzose uye bvunzo dzeropa. Izvi zvekutarisa zvinobatsira kuona kana mushonga uri kudzora kenza yako uye kana uri kusangana nemhedzisiro ipi neipi inonetsa. Zvichienderana nemigumisiro iyi, chirongwa chako chekurapa chinogona kuchinjwa.
Usambomira kutora lorlatinib usina kuzvikurukura nechiremba wako weoncologist kutanga. Kunyangwe iwe uchinzwa zvakanaka, mushonga unogona kunge uchiri kushanda kudzora maseru ekenza aunotadza kunzwa kana kuona. Chikwata chako chehutano chichakutungamira pakuti ungamira sei kurapwa zvakachengeteka kana nguva iyoyo yasvika.
Semishonga yese, lorlatinib inogona kukonzera mhedzisiro, kunyangwe kwete munhu wese anozviwana. Vanhu vazhinji vanogashira mushonga uyu zvakanaka, uye mhedzisiro inowanzo manejwa nerutsigiro rwakakodzera uye kuongorora.
Kunzwisisa zvekutarisira kunogona kukubatsira kuti unzwe wakagadzirira uye wakavimbika nezvekurapa kwako. Ngatitarisei mhedzisiro yakajairika yaungasangana nayo:
Mazhinji emhedzisiro iyi inenge iri nyoro kusvika pakati nepakati uye inogona kubatwa zvakanaka. Chikwata chako chekuchengetedza hutano chichakutarisa zvakanyanya uye chichapa nzira dzekukubatsira kuti unzwe wakasununguka sezvinobvira panguva yekurapa.
Nepo isingawanzoitika, vamwe vanhu vanogona kusangana nemhedzisiro yakakomba inoda kutariswa kwekurapa nekukasira. Iyi isingawanzoitiki asi yakakosha mhedzisiro inosanganisira:
Bata chikwata chako chekuchengetedza hutano nekukasira kana ukaona chero zviratidzo zvakakomba kana zvinonetsa. Vanovapo kuti vakutsigire uye vanogona kazhinji kupa mhinduro dzekukubatsira kuti uenderere mberi nekurapa zvakachengeteka.
Lorlatinib haina kukodzera munhu wese, uye chiremba wako achanyatsoongorora nhoroondo yako yekurapa asati akuraira. Iyi ongororo yakanyatsoitwa inobatsira kuona kuti mushonga wakachengeteka uye wakakodzera mamiriro ako chaiwo.
Haufaniri kutora lorlatinib kana uine allergic kwairi kana chero chimwe chezvinhu zvayo. Chiremba wako achakurukura chero allergies dzinonyatsozivikanwa newe usati watanga kurapwa. Vanhu vane mamiriro akati wandei aripo vanogona kuda kutariswa kwakakosha kana dzimwe nzira dzekurapa.
Zvimwe zvinhu zvinogona kukanganisa kana lorlatinib yakakukodzera:
Kana une pamuviri kana kuti unogona kuva nepamuviri, zvakakosha kuti ukurukure izvi nachiremba wako nekukasira. Lorlatinib inogona kukuvadza mwana asati aberekwa, saka kushandisa nzira dzinoshanda dzekudzivirira pamuviri kwakakosha panguva yekurapwa uye kwenguva yakati pashure pekurega mushonga.
Vashandi vehutano vachashanda newe kuti vaone kana lorlatinib iri iyo nzira yakanakisisa yekurapa zvichienderana nemamiriro ako ega uye nhoroondo yako yekurapa.
Lorlatinib inotengeswa pasi pezita rebrand rekuti Lorbrena. Iri ndiro zita rauchaona pabhodhoro rako remushonga uye pakurongwa kwemishonga.
Lorbrena inogadzirwa nePfizer uye inowanikwa chete nemushonga kubva kune oncologist wako. Pharmacy yako inogona kushandisa zita rimwe chete pakukurukura mushonga wako, saka zvinobatsira kuziva zvese zita re generic (lorlatinib) uye zita rebrand (Lorbrena).
Paunotora mushonga wako kana kukurukura mushonga wako nevashandi vehutano, unogona kuutaura nezita ripi zvaro. Mazita ese ari maviri anoreva mushonga mumwe chete une chinhu chimwe chete chinoshanda.
Mamwe maALK inhibitors akawanda anowanikwa kana lorlatinib isiri iyo sarudzo yakakunakira. Oncologist wako achatarisa zvinhu zvakasiyana-siyana pakusarudza mushonga wakakodzera mamiriro ako chaiwo.
Mamwe maALK inhibitors anosanganisira alectinib (Alecensa), ceritinib (Zykadia), crizotinib (Xalkori), uye brigatinib (Alunbrig). Imwe neimwe yemishonga iyi inoshanda zvakafanana nekudzivisa mapuroteni eALK, asi vane matambudziko akasiyana-siyana uye kushanda zvakasiyana-siyana pamhando dzakasiyana dzeALK mutations.
Kusarudza kwe ALK inhibitor kunoenderana nezvinhu zvakawanda zvinosanganisira kana wakatambira kurapwa kwe ALK inhibitor kare, rudzi rwakasiyana rwe ALK mutation yaunayo, uye kana kenza yako yakapararira kuuropi hwako. Chiremba wako achakurukura sarudzo idzi newe kana lorlatinib isina kukodzera kana ikamira kushanda zvakanaka.
Vose lorlatinib na alectinib vanoshanda ALK inhibitors, asi mumwe nemumwe ane zvakanakira zvakasiyana. Sarudzo yakanaka inoenderana nemamiriro ako ega, kusanganisira rudzi rwako rwekenza uye nhoroondo yekurapa.
Lorlatinib inowanzo shanda zvakanyanya pamusoro peimwe ALK mutations dzave dzisingashandi kune mamwe ALK inhibitors. Zvakare zvakanaka zvikuru pakusvika maseru ekenza muuropi, izvo zvinoita kuti ive yakakosha pakurapa brain metastases.
Alectinib, kune rumwe rutivi, inogona kukonzera mashoma cognitive side effects uye inowanzo shandiswa seyekutanga-mutsara kurapwa kwekenza yemapapu itsva ye ALK-positive. Iyo zvakare ine yakanyatso gadzirwa kuchengetedzeka profile uye inowanzo shivirirwa zvakanaka.
Oncologist wako achafunga nezvezvinhu zvakaita senhoroondo yako yekurapa, huwandu hwekenza yako, uye hutano hwako hwese pakusarudza pakati pemishonga iyi. Chinangwa ndechekusarudza kurapwa kunokupa mukana wakanaka wekudzora kenza yako uchichengetedza hupenyu hwako.
Lorlatinib inogona kukanganisa rhythm yemoyo, saka vanhu vane mamiriro emoyo aripo vanoda kunyatso tariswa. Chiremba wako achaongorora hutano hwemoyo wako usati watanga kurapwa uye anogona kuraira bvunzo dzemoyo senge EKG.
Kana uine chirwere chemoyo, izvi hazvirevi kuti haugone kutora lorlatinib, asi uchada kuongororwa kakawanda. Chiremba wako wemoyo uye oncologist vachashanda pamwechete kuti vave nechokwadi chekuti kurapwa kwako kwakachengeteka sezvinobvira. Vanogona kuchinja mushonga wako kana kukurudzira kuongororwa kwemoyo kwakawedzerwa panguva yekurapa.
Kana netsaona ukatora lorlatinib yakawanda kupfuura yakarairwa, taura nachiremba wako kana nzvimbo yekudzora muchetura nekukasira. Usamirira kuti uone kana uine zviratidzo, sezvo kuwana rubatsiro nekukurumidza kwakakosha.
Chengeta bhodhoro rako remushonga newe paunofona, sezvo vanopa hutano vachazoda kuziva chaizvo kuti wakatora mushonga wakawanda sei. Paunenge uchimirira gwara, usatore mamwe ma doses uye zviise pasi pekutariswa kune chero zviratidzo zvisingawanzoitiki zvakaita senausea yakanyanya, dzungu, kana kuvhiringidzika.
Kana ukarasikirwa nedose uye zvapfuura maawa makumi maviri kubva panguva yako yenguva dzose, tora dose yakarasika pakarepo paunorangarira. Kana zvapfuura maawa makumi maviri, siya dose yakarasika uye tora dose yako inotevera panguva yakajairika.
Usambofa wakatora ma doses maviri panguva imwe chete kuti ugadzirise dose yakarasika, sezvo izvi zvinogona kuwedzera njodzi yako yezvipingamupinyi. Kana iwe uchikanganwa ma doses kazhinji, taura nechikwata chako chehutano nezve nzira dzekukubatsira kurangarira, senge kumisa maalarm efoni kana kushandisa chirongwa chemapiritsi.
Unofanirwa kungomira kutora lorlatinib kana chiremba wako akukurudzira kuti uite kudaro. Sarudzo iyi inowanzoenderana nekuti mushonga uri kudzora sei kenza yako uye kana uri kusangana nezvipingamupinyi zvinogoneka.
Chiremba wako achashandisa ma scans enguva dzose uye bvunzo dzeropa kuti aongorore kufambira mberi kwako. Kana kenza ikatanga kukura zvakare kana ukawana zvipingamupinyi zvakakomba zvisingakwanise kutarisirwa, chiremba wako angakurudzira kumisa lorlatinib uye kuyedza nzira yekurapa yakasiyana.
Zvakanaka kuderedza kunwa doro uchitora lorlatinib, nekuti zvese zvinogona kukanganisa chiropa chako uye tsinga dzako. Doro rinogona kuwedzera mamwe matambudziko akadai sedzungu, kuvhiringika, kana shanduko dzemafungiro.
Kana ukasarudza kunwa doro dzimwe nguva, ita izvi zvine mwero uye teerera kuti unonzwa sei. Taura nachiremba wako nezvekuti chii chakakodzera mamiriro ako chaiwo, sezvo vachiziva nhoroondo yako yese yekurapa uye vanogona kupa gwara rako pachako.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.